INTREANT

Details for Australian Trade Mark No. 1333370 (hide)

Owner Merck Sharp & Dohme Corp.

Convention US 8 May 2009 77732693

IR Number 1018826

Various Convention priority claimed: 8 May 2009, United States of America, No. 77732693 in respect of PHARMACEUTICAL PREPARATIONS FOR THE TREATMENT OF DIABETES, CARDIOVASCULAR DISEASES AND DISORDERS, DISEASES AND DISORDERS OF THE CENTRAL NERVOUS SYSTEM, CANCER, R

Filing Date 28 October 2009

Classes

Class 5 Pharmaceutical preparations for the treatment of diabetes, cardiovascular diseases and disorders, diseases and disorders of the central nervous system, cancer, respiratory diseases and disorders, musculoskeletal disorders, osteoporosis, anti-infective preparations, anti-viral preparations, immunological preparations, analgesic preparations, ophthalmic preparations, and vaccine preparations

Event Publications

17 December 2009 Application filed

17 December 2009 Application Accepted

8 April 2010 Trade Mark Registered/Protected

8 April 2010 Application/IR Name Amendment and Changes

  The owner's/holder's name has been changed to Merck Sharp & Dohme Corp..

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the ATMOSS Australian Trade Mark On-line Search System.

Next and Previous Trademarks/Applications

1333371-SWOX

1333369-UTREYSA